Welcome to Paid Research Studies

  • Condition:   Cystinuria
    Interventions:   Dietary Supplement: Alpha lipoic acid;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

  • Condition:   Cystic Fibrosis
    Interventions:   Dietary Supplement: Acute Antioxidant Cocktail;   Dietary Supplement: Chronic Antioxidant Cocktail;   Other: Placebo
    Sponsor:   Augusta University

  • Condition:   Hypertension
    Interventions:   Dietary Supplement: Oral Antioxidant;   Other: Exercise rehabilitation
    Sponsor:   VA Office of Research and Development

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: Lipoic acid;   Drug: Placebo
    Sponsor:   VA Office of Research and Development

  • Condition:   Mental Health Disorders
    Interventions:   Dietary Supplement: PTSD/GAD Antioxidant;   Dietary Supplement: PTSD/GAD Placebo;   Dietary Supplement: Healthy Control Antioxidant;   Dietary Supplement: Healthy Control Placebo
    Sponsor:   Virginia Commonwealth University

  • Conditions:   Chronic Obstructive Pulmonary Disease;   Pulmonary Artery Hypertension;   Heart Failure;   Hypertension
    Interventions:   Other: Maximum Exercise Tests;   Drug: BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate;   Drug: BQ-123;   Drug: Fexofenadine, Ranitidine;   Other: Angiotensin-II, Valsartan;   Drug: Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, Phentolamine;   Drug: BQ-123, MitoQ, BH4
    Sponsor:   Russell Richardson

  • Condition:   Heart Failure With Reduced Ejection Fraction
    Interventions:   Dietary Supplement: Antioxidant;   Dietary Supplement: Tetrahydrobiopterin (BH4);   Other: Exercise training
    Sponsors:   VA Office of Research and Development;   University of Utah

  • Condition:   Diabetes Mellitus, Type 1
    Interventions:   Dietary Supplement: Antioxidant Cocktail;   Dietary Supplement: Resveratrol;   Other: Placebo
    Sponsors:   Augusta University;   National Heart, Lung, and Blood Institute (NHLBI)

  • Condition:   Center-involved Diabetic Macular Edema (CI-DME)
    Interventions:   Dietary Supplement: Diabetes Visual Function Study (DiVFuSS) softgels;   Other: canola oil placebo softgels, 2 per day
    Sponsors:   ZeaVision, LLC;   Sound Retina
    Not yet recruiting

  • Conditions:   Mucopolysaccharidosis Disorders;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Alpha-Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Glycoprotein Metabolic Disorders;   Sphingolipidoses;   Recessive Leukodystrophies;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann-Pick B;   Niemann-Pick C Subtype 2;   Sphingomyelin Deficiency;   Peroxisomal Disorders;   Adrenoleukodystrophy With Cerebral Involvement;   Zellweger Syndrome;   Neonatal Adrenoleukodystrophy;   Infantile Refsum Disease;   Acyl-CoA Oxidase Deficiency;   D-Bifunctional Enzyme Deficiency;   Multifunctional Enzyme Deficiency;   Alpha-methylacyl-CoA Racmase Deficiency;   Mitochondrial Neurogastrointestingal Encephalopathy;   Severe Osteopetrosis;   Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation);   Inherited Metabolic Disorders
    Interventions:   Biological: Stem Cell Transplantation;   Drug: IMD Preparative Regimen;   Drug: Osteopetrosis Only Preparative Regimen;   Drug: Osteopetrosis Haploidentical Only Preparative Regimen;   Drug: cALD SR-A (Standard-Risk, Regimen A);   Drug: cALD SR-B (Standard-Risk, Regimen B);   Drug: cALD HR-D (High-Risk, Regimen C);   Drug: cALD HR-D (High-Risk, Regimen D)
    Sponsor:   Masonic Cancer Center, University of Minnesota